"Vector" will begin clinical trials of a vaccine against coronavirus 15 July
The head of Rospotrebnadzor Anna Popova said that preclinical studies of the vaccine from COVID-19 in the center "Vector" was completed July 15, is scheduled to begin testing on volunteers.
"Colleagues have done preclinical studies. They were successful. And we almost have every reason to be confident that it will, as we promised, July 15, we expect to enter the clinic," she said in an interview Naila Asker-zade, the TV channel "Russia 1", in response to a question.
Earlier that research on the vaccine against the coronavirus, a new type will begin in the "Vector" on 15 July, in an interview with RIA Novosti reported the Director of the centre of Rinat Maksyutov.
Relevant data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.